This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Interventions
The two screening strategies were wireless capsule endoscopy (Pillcam Colon, Given Imaging Ltd, Yoqneam, Israel) and colonoscopy. In both strategies patients were assumed to be screened every 10 years from the age of 50 years until the age of 80 years, and both strategies were compared with no screening.
Location/setting
USA/secondary care.
Methods

Analytical approach:
A Markov model was constructed to extrapolate clinical outcomes and compare the cost-effectiveness of the screening strategies. The health states were clearly reported. The time horizon of the model was the patient's lifetime. The authors reported that a societal perspective was adopted.
Effectiveness data:
The effectiveness data were derived from the published literature. The estimates for the base-case analysis were selected in consultation with a principal investigator and an expert panel. The main clinical parameters included the transition probabilities for the different health states, the sensitivity and specificity of the two screening strategies for different sizes of polyps and CRC, and the screening-related complication rates.
Monetary benefit and utility valuations:
Not relevant.
Measure of benefit:
The authors used life-years saved (LYS) due to screening. Future LYS were appropriately discounted at an annual rate of 3%.
Cost data:
The cost categories included the costs of colonoscopy with and without polypectomy, capsule endoscopy, treating screening complications and different forms of CRC, and the productivity losses due to screening (including escort time). The cost of capsule endoscopy was taken from literature estimates of capsule endoscopy of the bowel. Most other cost data were taken from Medicare reimbursement figures. The costs were reported for the price year 2007 and
